The preparation has been assessed following the conventional
method of the Dangerous Preparation Directive 1999/45/EC.
See Sections 3 and 15 for details.
Exposure to component solvent vapour concentrations in excess of
the stated occupational exposure limit may result in adverse
health effects such as mucous membrane and respiratory system
irritation and adverse effect on kidney, liver and central nervous
system. Symptoms and signs include headache, dizziness, fatigue,
muscular weakness, drowsiness and in extreme cases, loss of
consciousness.
Repeated and prolonged exposure to solvents at levels
significantly above OELs may lead to the development of
long-lasting central nervous system disorders such as chronic
toxic encephalopathy, signs of toxicity include changes in
behaviour and memory.
Solvents may cause some of the above effects by absorption through
the skin. Repeated or prolonged contact with the preparation may
cause removal of natural fat from the skin resulting in
non-allergic contact dermatitis and absorption through the skin.
The liquid splashed in the eyes may cause irritation and
reversible damage.
Based on the properties of the isocyanate components and
considering toxicological data on similar product, this product
may cause acute irritation and/or sensitization of the respiratory
system leading to an asthmatic condition, wheeziness and tightness
of the chest. Sensitized persons may subsequently show asthmatic
symptoms when exposed to atmospheric concentrations well below the
occupational exposure limit. Repeated inhalation may lead to a
permanent respiratory disability.
_______________________________________________________